Literature DB >> 12571261

Inheritance and drug response.

Richard Weinshilboum1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12571261     DOI： 10.1056/NEJMra020021

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  172 in total

1.  Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study.

Authors:  Haiyan Li; Kathleen Butler; Li Yang; Zhenghua Yang; Renli Teng
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

2.  Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

3.  Integrating pharmacokinetics knowledge into a drug ontology: as an extension to support pharmacogenomics.

Authors:  C G Chute; J S Carter; M S Tuttle; M Haber; S H Brown
Journal:  AMIA Annu Symp Proc       Date:  2003

Review 4.  The role of cost-effectiveness analysis in the era of pharmacogenomics.

Authors:  Christopher R Flowers; David Veenstra
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  D919G polymorphism of methionine synthase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients.

Authors:  Yan Zhang; Minmin Zhang; Tianhua Niu; Xin Xu; Guoying Zhu; Yong Huo; Changzhong Chen; Xiaobin Wang; Houxun Xing; Shaojie Peng; Aiqun Huang; Xiumei Hong; Xiping Xu
Journal:  J Hum Genet       Date:  2004-05-18       Impact factor: 3.172

6.  Delivering a pharmacogenetic service: is there a role for genetic counselors?

Authors:  Alice Callard; William Newman; Katherine Payne
Journal:  J Genet Couns       Date:  2011-11-04       Impact factor: 2.537

7.  Benefits of pharmacogenomics in drug development-earlier launch of drugs and less adverse events.

Authors:  Wataru Ohashi; Hiroshi Tanaka
Journal:  J Med Syst       Date:  2009-04-09       Impact factor: 4.460

Review 8.  [Pharmacogenetics].

Authors:  H F Merk
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

9.  Localizing putative markers in genetic association studies by incorporating linkage disequilibrium into bayesian hierarchical models.

Authors:  Brooke L Fridley; Gregory D Jenkins
Journal:  Hum Hered       Date:  2010-06-10       Impact factor: 0.444

10.  Consequences of POR mutations and polymorphisms.

Authors:  Walter L Miller; Vishal Agrawal; Duanpen Sandee; Meng Kian Tee; Ningwu Huang; Ji Ha Choi; Kari Morrissey; Kathleen M Giacomini
Journal:  Mol Cell Endocrinol       Date:  2010-11-09       Impact factor: 4.102
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.